BioAtla BCAB
OTC BCAB
$1.60 +0.32 (+25.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

BioAtla (BCAB) EBT Margin (2020 - 2026)

Updated

BioAtla's EBT Margin was 3.74% in Q2 2026.

Analysis

BioAtla (BCAB) EBT Margin (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioAtla's EBT Margin was -374.89% through Jun 30, 2026, up 187.80 percentage points year-over-year; for FY2025, it was -2923.10%, down 2281.52 percentage points from FY2024.

  • EBT Margin shows a five-year change of +4393.45 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was -641.58% in FY2024 and -38437.20% in FY2021 (-31120.65 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 BioAtla 2.66 Mn 2.66 Mn - 3.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.74%
Dec 31, 2025 -459.10%
Sep 30, 2024 -96.16%
Jun 30, 2021 -12,152.40%
Sep 30, 2020 -5,380.00%
Jun 30, 2020 -2,775.26%
Mar 31, 2020 -1,855.06%
API Access

BioAtla EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY